The role of bacteria and pattern-recognition receptors in Crohn's disease (original) (raw)

• Sartor, R. B. Enteric microflora in IBD: pathogens or commensals? Inflamm. Bowel Dis. 3, 230–235 (1997).
  Google Scholar
• Yamamoto, T., Allan, R. N. & Keighley, M. R. Effect of fecal diversion alone on perianal Crohn's disease. World J. Surg. 24, 1258–1262 (2000).
  CAS PubMed Google Scholar
• Rutgeerts, P. et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 338, 771–774 (1991).
  CAS PubMed Google Scholar
• Zelas, P. & Jagelman, D. G. Loop illeostomy in the management of Crohn's colitis in the debilitated patient. Ann. Surg. 191, 164–168 (1980).
  CAS PubMed PubMed Central Google Scholar
• McIlrath, D. C. Diverting ileostomy or colostomy in the management of Crohn's disease of the colon. Arch. Surg. 103, 308–310 (1971).
  CAS PubMed Google Scholar
• D'Haens, G. R. et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114, 262–267 (1998).
  CAS PubMed Google Scholar
• Shafran, I. & Burgunder, P. Adjunctive antibiotic therapy with rifaximin may help reduce Crohn's disease activity. Dig. Dis. Sci. 55, 1079–1084 (2010).
  CAS PubMed Google Scholar
• Prantera, C. et al. Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin. Aliment. Pharmacol. Ther. 23, 1117–1125 (2006).
  CAS PubMed Google Scholar
• Arnold, G. L., Beaves, M. R., Pryjdun, V. O. & Mook, W. J. Preliminary study of ciprofloxacin in active Crohn's disease. Inflamm. Bowel Dis. 8, 10–15 (2002).
  PubMed Google Scholar
• Steinhart, A. H. et al. Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial. Gastroenterology 123, 33–40 (2002).
  CAS PubMed Google Scholar
• Colombel, J. F. et al. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID). Am. J. Gastroenterol. 94, 674–678 (1999).
  CAS PubMed Google Scholar
• Prantera, C. et al. An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am. J. Gastroenterol. 91, 328–332 (1996).
  CAS PubMed Google Scholar
• Greenbloom, S. L., Steinhart, A. H. & Greenberg, G. R. Combination ciprofloxacin and metronidazole for active Crohn's disease. Can. J. Gastroenterol. 12, 53–56 (1998).
  CAS PubMed Google Scholar
• Sutherland, L. et al. Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut 32, 1071–1075 (1991).
  CAS PubMed PubMed Central Google Scholar
• Leiper, K., Morris, A. I. & Rhodes, J. M. Open label trial of oral clarithromycin in active Crohn's disease. Aliment. Pharmacol. Ther. 14, 801–806 (2000).
  CAS PubMed Google Scholar
• Rahimi, R., Nikfar, S., Rezaie, A. & Abdollahi, M. A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's disease. Clin. Ther. 28, 1983–1988 (2006).
  CAS PubMed Google Scholar
• Nell, S., Suerbaum, S. & Josenhans, C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat. Rev. Microbiol. 8, 564–577 (2010).
  CAS PubMed Google Scholar
• Guarner, F. The intestinal flora in inflammatory bowel disease: normal or abnormal? Curr. Opin. Gastroenterol. 21, 414–418 (2005).
  PubMed Google Scholar
• Hooper, L. V., Midtvedt, T. & Gordon, J. I. How host–microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 22, 283–307 (2002).
  CAS PubMed Google Scholar
• Tamboli, C. P., Neut, C., Desreumaux, P. & Colombel, J. F. Dysbiosis in inflammatory bowel disease. Gut 53, 1–4 (2004).
  CAS PubMed PubMed Central Google Scholar
• Tannock, G. W. Analysis of the intestinal microflora using molecular methods. Eur. J. Clin. Nutr. 56 (Suppl. 4), S44–S49 (2002).
  CAS PubMed Google Scholar
• Zoetendal, E. G., Rajilic-Stojanovic, M. & de Vos, W. M. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57, 1605–1615 (2008).
  CAS PubMed Google Scholar
• Packey, C. D. & Sartor, R. B. Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr. Opin. Infect. Dis. 22, 292–301 (2009).
  PubMed PubMed Central Google Scholar
• Rehman, A. et al. Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients. J. Med. Microbiol. 59, 1114–1122 (2010).
  CAS PubMed Google Scholar
• Frank, D. N. et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl Acad. Sci. USA 104, 13780–13785 (2007).
  CAS PubMed PubMed Central Google Scholar
• Baumgart, M. et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J. 1, 403–418 (2007).
  CAS PubMed Google Scholar
• Kotlowski, R., Bernstein, C. N., Sepehri, S. & Krause, D. O. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 56, 669–675 (2007).
  CAS PubMed Google Scholar
• Gophna, U., Sommerfeld, K., Gophna, S., Doolittle, W. F. & Veldhuyzen van Zanten, S. J. Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J. Clin. Microbiol. 44, 4136–4141 (2006).
  CAS PubMed PubMed Central Google Scholar
• Martinez-Medina, M., Aldeguer, X., Gonzalez-Huix, F., Acero, D. & Garcia-Gil, L. J. Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis. Inflamm. Bowel Dis. 12, 1136–1145 (2006).
  PubMed Google Scholar
• Swidsinski, A., Weber, J., Loening-Baucke, V., Hale, L. P. & Lochs, H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J. Clin. Microbiol. 43, 3380–3389 (2005).
  PubMed PubMed Central Google Scholar
• Ott, S. J. et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53, 685–693 (2004).
  CAS PubMed PubMed Central Google Scholar
• Prindiville, T., Cantrell, M. & Wilson, K. H. Ribosomal DNA sequence analysis of mucosa-associated bacteria in Crohn's disease. Inflamm. Bowel Dis. 10, 824–833 (2004).
  PubMed Google Scholar
• Swidsinski, A. et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 122, 44–54 (2002).
  PubMed Google Scholar
• Kleessen, B., Kroesen, A. J., Buhr, H. J. & Blaut, M. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand. J. Gastroenterol. 37, 1034–1041 (2002).
  CAS PubMed Google Scholar
• Conte, M. P. et al. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 55, 1760–1767 (2006).
  CAS PubMed PubMed Central Google Scholar
• Bibiloni, R., Mangold, M., Madsen, K. L., Fedorak, R. N. & Tannock, G. W. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J. Med. Microbiol. 55, 1141–1149 (2006).
  PubMed Google Scholar
• Kang, S. et al. Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray. Inflamm. Bowel Dis. 16, 2034–2042 (2010).
  PubMed Google Scholar
• Mondot, S. et al. Highlighting new phylogenetic specificities of Crohn's disease microbiota. Inflamm. Bowel Dis. 17, 185–192 (2011).
  CAS PubMed Google Scholar
• Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65 (2010).
  CAS PubMed PubMed Central Google Scholar
• Dicksved, J. et al. Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J. 2, 716–727 (2008).
  CAS PubMed Google Scholar
• Takaishi, H. et al. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. Int. J. Med. Microbiol. 298, 463–472 (2008).
  CAS PubMed Google Scholar
• Manichanh, C. et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55, 205–211 (2006).
  CAS PubMed PubMed Central Google Scholar
• Sokol, H. et al. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm. Bowel Dis. 12, 106–111 (2006).
  PubMed Google Scholar
• Seksik, P. et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52, 237–242 (2003).
  CAS PubMed PubMed Central Google Scholar
• Lupp, C. et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2, 204 (2007).
  CAS PubMed Google Scholar
• Garrett, W. S. et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 8, 292–300 (2010).
  CAS PubMed PubMed Central Google Scholar
• Kirkwood, C. D. et al. Mycobacterium avium subspecies paratuberculosis in children with early-onset Crohn's disease. Inflamm. Bowel Dis. 15, 1643–1655 (2009).
  PubMed Google Scholar
• Di Sabatino, A. et al. Detection of Mycobacterium avium subsp. paratuberculosis (MAP)-specific IS900 DNA and antibodies against MAP peptides and lysate in the blood of Crohn's disease patients. Inflamm. Bowel Dis. doi:10.1002/ibd.21461.
  PubMed Google Scholar
• Mendoza, J. L. et al. High prevalence of viable Mycobacterium avium subspecies paratuberculosis in Crohn's disease. World J. Gastroenterol. 16, 4558–4563 (2010).
  CAS PubMed PubMed Central Google Scholar
• Shin, A. R. et al. Identification of seroreactive proteins in the culture filtrate antigen of Mycobacterium avium ssp. paratuberculosis human isolates to sera from Crohn's disease patients. FEMS Immunol. Med. Microbiol. 58, 128–137 (2010).
  CAS PubMed Google Scholar
• Bach, H. et al. Immunogenicity of Mycobacterium avium subsp. paratuberculosis proteins in Crohn's disease patients. Scand. J. Gastroenterol. doi:10.3109/00365521.
• Hermon-Taylor, J. Mycobacterium avium subspecies paratuberculosis, Crohn's disease and the Doomsday scenario. Gut Pathog. 1, 15 (2009).
  PubMed PubMed Central Google Scholar
• Sibartie, S. et al. Mycobacterium avium subsp. paratuberculosis (MAP) as a modifying factor in Crohn's disease. Inflamm. Bowel Dis. 16, 296–304 (2010).
  PubMed Google Scholar
• Feller, M. et al. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect. Dis. 7, 607–613 (2007).
  PubMed Google Scholar
• Abubakar, I., Myhill, D., Aliyu, S. H. & Hunter, P. R. Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: a systematic review and meta-analysis. Inflamm. Bowel Dis. 14, 401–410 (2008).
  CAS PubMed Google Scholar
• Boudeau, J., Glasser, A. L., Masseret, E., Joly, B. & Darfeuille-Michaud, A. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect. Immun. 67, 4499–4509 (1999).
  CAS PubMed PubMed Central Google Scholar
• Glasser, A. L. et al. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect. Immun. 69, 5529–5537 (2001).
  CAS PubMed PubMed Central Google Scholar
• Darfeuille-Michaud, A. et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127, 412–421 (2004).
  PubMed Google Scholar
• Martin, H. M. et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 127, 80–93 (2004).
  CAS PubMed Google Scholar
• Martinez-Medina, M. et al. Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease. Inflamm. Bowel Dis. 15, 872–882 (2009).
  PubMed Google Scholar
• Meconi, S. et al. Adherent-invasive Escherichia coli isolated from Crohn's disease patients induce granulomas in vitro. Cell. Microbiol. 9, 1252–1261 (2007).
  CAS PubMed Google Scholar
• Rolhion, N., Carvalho, F. A. & Darfeuille-Michaud, A. OmpC and the sigma(E) regulatory pathway are involved in adhesion and invasion of the Crohn's disease-associated Escherichia coli strain LF82. Mol. Microbiol. 63, 1684–1700 (2007).
  CAS PubMed Google Scholar
• Bringer, M. A., Rolhion, N., Glasser, A. L. & Darfeuille-Michaud, A. The oxidoreductase DsbA plays a key role in the ability of the Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 to resist macrophage killing. J. Bacteriol. 189, 4860–4871 (2007).
  CAS PubMed PubMed Central Google Scholar
• Rolhion, N. et al. Abnormally expressed ER stress response chaperone Gp96 in CD favours adherent-invasive Escherichia coli invasion. Gut 59, 1355–1362 (2010).
  CAS PubMed Google Scholar
• Barnich, N. et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J. Clin. Invest. 117, 1566–1574 (2007).
  CAS PubMed PubMed Central Google Scholar
• Carvalho, F. A. et al. Crohn's disease-associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin. Inflamm. Bowel Dis. 14, 1051–1060 (2008).
  PubMed Google Scholar
• Zhang, L. et al. Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease. J. Clin. Microbiol. 47, 453–455 (2009).
  PubMed Google Scholar
• Man, S. M. et al. Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease. Inflamm. Bowel Dis. 16, 1008–1016 (2010).
  PubMed Google Scholar
• Man, S. M. et al. Host attachment, invasion, and stimulation of proinflammatory cytokines by Campylobacter concisus and other non-Campylobacter jejuni Campylobacter species. J. Infect. Dis. 202, 1855–1865 (2010).
  CAS PubMed Google Scholar
• Istivan, T. S., Coloe, P. J., Fry, B. N., Ward, P. & Smith, S. C. Characterization of a haemolytic phospholipase A(2) activity in clinical isolates of Campylobacter concisus. J. Med. Microbiol. 53, 483–493 (2004).
  CAS PubMed Google Scholar
• Istivan, T. S., Smith, S. C., Fry, B. N. & Coloe, P. J. Characterization of Campylobacter concisus hemolysins. FEMS Immunol. Med. Microbiol. 54, 224–235 (2008).
  CAS PubMed Google Scholar
• Kaakoush, N. O. et al. The secretome of Campylobacter concisus. FEBS J. 277, 1606–1617 (2010).
  CAS PubMed Google Scholar
• Engberg, J. et al. Campylobacter concisus: an evaluation of certain phenotypic and genotypic characteristics. Clin. Microbiol. Infect. 11, 288–295 (2005).
  CAS PubMed Google Scholar
• Aabenhus, R., Stenram, U., Andersen, L. P., Permin, H. & Ljungh, A. First attempt to produce experimental Campylobacter concisus infection in mice. World J. Gastroenterol. 14, 6954–6959 (2008).
  PubMed PubMed Central Google Scholar
• Hansen, R., Thomson, J. M., Fox, J. G., El-Omar, E. M. & Hold, G. L. Could Helicobacter organisms cause inflammatory bowel disease? FEMS Immunol. Med. Microbiol. doi:10.1111/j.1574-695X.2010.00744.x.
  Google Scholar
• Solnick, J. V. & Schauer, D. B. Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases. Clin. Microbiol. Rev. 14, 59–97 (2001).
  CAS PubMed PubMed Central Google Scholar
• Bohr, U. R. et al. Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease. J. Clin. Microbiol. 42, 2766–2768 (2004).
  CAS PubMed PubMed Central Google Scholar
• Zhang, L., Day, A., McKenzie, G. & Mitchell, H. Nongastric Helicobacter species detected in the intestinal tract of children. J. Clin. Microbiol. 44, 2276–2279 (2006).
  CAS PubMed PubMed Central Google Scholar
• Man, S. M., Zhang, L., Day, A. S., Leach, S. & Mitchell, H. Detection of enterohepatic and gastric Helicobacter species in fecal specimens of children with Crohn's disease. Helicobacter 13, 234–238 (2008).
  CAS PubMed Google Scholar
• Kaakoush, N. O. et al. Detection of Helicobacteraceae in intestinal biopsies of children with Crohn's disease. Helicobacter 15, 549–557 (2010).
  PubMed Google Scholar
• Laharie, D. et al. Association between entero-hepatic Helicobacter species and Crohn's disease: a prospective cross-sectional study. Aliment. Pharmacol. Ther. 30, 283–293 (2009).
  CAS PubMed Google Scholar
• Varon, C. et al. Study of Helicobacter pullorum proinflammatory properties on human epithelial cells in vitro. Gut 58, 629–635 (2009).
  CAS PubMed Google Scholar
• Bell, S. J., Chisholm, S. A., Owen, R. J., Borriello, S. P. & Kamm, M. A. Evaluation of Helicobacter species in inflammatory bowel disease. Aliment. Pharmacol. Ther. 18, 481–486 (2003).
  CAS PubMed Google Scholar
• Grehan, M., Danon, S., Lee, A., Daskalopoulos, G. & Mitchell, H. Absence of mucosa-associated colonic Helicobacters in an Australian urban population. J. Clin. Microbiol. 42, 874–876 (2004).
  PubMed PubMed Central Google Scholar
• Wagner, J. et al. Identification and characterisation of Pseudomonas 16S ribosomal DNA from ileal biopsies of children with Crohn's disease. PLoS ONE 3, e3578 (2008).
  PubMed PubMed Central Google Scholar
• Wei, B. et al. Pseudomonas fluorescens encodes the Crohn's disease-associated I2 sequence and T-cell superantigen. Infect. Immun. 70, 6567–6575 (2002).
  CAS PubMed PubMed Central Google Scholar
• Spivak, J. et al. Antibodies to I2 predict clinical response to fecal diversion in Crohn's disease. Inflamm. Bowel Dis. 12, 1122–1130 (2006).
  PubMed Google Scholar
• Ashorn, S. et al. Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease. Inflamm. Bowel Dis. 15, 199–205 (2009).
  PubMed Google Scholar
• Lamps, L. W. et al. Pathogenic Yersinia DNA is detected in bowel and mesenteric lymph nodes from patients with Crohn's disease. Am. J. Surg. Pathol. 27, 220–227 (2003).
  PubMed Google Scholar
• Safa, G., Loppin, M., Tisseau, L. & Lamoril, J. Cutaneous aseptic neutrophilic abscesses and Yersinia enterocolitica infection in a case subsequently diagnosed as Crohn's disease. Dermatology 217, 340–342 (2008).
  CAS PubMed Google Scholar
• Zippi, M. et al. Mesenteric adenitis caused by Yersinia pseudotubercolosis in a patient subsequently diagnosed with Crohn's disease of the terminal ileum. World J. Gastroenterol. 12, 3933–3935 (2006).
  PubMed PubMed Central Google Scholar
• Saebo, A., Vik, E., Lange, O. J. & Matuszkiewicz, L. Inflammatory bowel disease associated with Yersinia enterocolitica O:3 infection. Eur. J. Intern. Med. 16, 176–182 (2005).
  PubMed Google Scholar
• Goodman, M. J., Pearson, K. W., McGhie, D., Dutt, S. & Deodhar, S. G. Campylobacter and Giardia lamblia causing exacerbation of inflammatory bowel disease. Lancet 2, 1247 (1980).
  CAS PubMed Google Scholar
• Newman, A. & Lambert, J. R. Campylobacter jejuni causing flare-up in inflammatory bowel disease. Lancet 2, 919 (1980).
  CAS PubMed Google Scholar
• Gradel, K. O. et al. Increased short- and long-term risk of inflammatory bowel disease after Salmonella or Campylobacter gastroenteritis. Gastroenterology 137, 495–501 (2009).
  PubMed Google Scholar
• Ternhag, A., Torner, A., Svensson, A., Ekdahl, K. & Giesecke, J. Short- and long-term effects of bacterial gastrointestinal infections. Emerg. Infect. Dis. 14, 143–148 (2008).
  PubMed PubMed Central Google Scholar
• Hugot, J. P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599–603 (2001).
  CAS PubMed Google Scholar
• Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603–606 (2001).
  CAS PubMed Google Scholar
• Leulier, F. & Lemaitre, B. Toll-like receptors--taking an evolutionary approach. Nat. Rev. Genet. 9, 165–178 (2008).
  CAS PubMed Google Scholar
• Silva, M. A. et al. Dendritic cells and toll-like receptors 2 and 4 in the ileum of Crohn's disease patients. Dig. Dis. Sci. 53, 1917–1928 (2008).
  CAS PubMed Google Scholar
• Szebeni, B. et al. Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease. Clin. Exp. Immunol. 151, 34–41 (2008).
  CAS PubMed PubMed Central Google Scholar
• Cario, E. & Podolsky, D. K. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68, 7010–7017 (2000).
  CAS PubMed PubMed Central Google Scholar
• Frolova, L., Drastich, P., Rossmann, P., Klimesova, K. & Tlaskalova-Hogenova, H. Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis. J. Histochem. Cytochem. 56, 267–274 (2008).
  CAS PubMed PubMed Central Google Scholar
• Bryant, C. E., Spring, D. R., Gangloff, M. & Gay, N. J. The molecular basis of the host response to lipopolysaccharide. Nat. Rev. Microbiol. 8, 8–14 (2010).
  CAS PubMed Google Scholar
• Franchimont, D. et al. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53, 987–992 (2004).
  CAS PubMed PubMed Central Google Scholar
• Ouburg, S. et al. The toll-like receptor 4 (TLR4) Asp299Gly polymorphism is associated with colonic localisation of Crohn's disease without a major role for the Saccharomyces cerevisiae mannan–LBP–CD14–TLR4 pathway. Gut 54, 439–440 (2005).
  CAS PubMed PubMed Central Google Scholar
• Hume, G. E. et al. Novel NOD2 haplotype strengthens the association between TLR4 Asp299gly and Crohn's disease in an Australian population. Inflamm. Bowel Dis. 14, 585–590 (2008).
  PubMed Google Scholar
• Gazouli, M. et al. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J. Gastroenterol. 11, 681–685 (2005).
  CAS PubMed PubMed Central Google Scholar
• Zouiten-Mekki, L. et al. Toll-like receptor 4 (TLR4) polymorphisms in Tunisian patients with Crohn's disease: genotype–phenotype correlation. BMC Gastroenterol. 9, 62 (2009).
  PubMed PubMed Central Google Scholar
• Lakatos, P. L. et al. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations. World J. Gastroenterol. 11, 1489–1495 (2005).
  CAS PubMed PubMed Central Google Scholar
• Hong, J. et al. TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort. J. Gastroenterol. Hepatol. 22, 1760–1766 (2007).
  CAS PubMed Google Scholar
• Arbour, N. C. et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25, 187–191 (2000).
  CAS PubMed Google Scholar
• Lorenz, E., Mira, J. P., Frees, K. L. & Schwartz, D. A. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch. Intern. Med. 162, 1028–1032 (2002).
  CAS PubMed Google Scholar
• Kiechl, S. et al. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347, 185–192 (2002).
  CAS PubMed Google Scholar
• Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740–745 (2000).
  CAS PubMed Google Scholar
• Pedersen, G., Andresen, L., Matthiessen, M. W., Rask-Madsen, J. & Brynskov, J. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium. Clin. Exp. Immunol. 141, 298–306 (2005).
  CAS PubMed PubMed Central Google Scholar
• Torok, H. P. et al. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease. Am. J. Gastroenterol. 104, 1723–1733 (2009).
  PubMed Google Scholar
• Pierik, M. et al. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm. Bowel Dis. 12, 1–8 (2006).
  PubMed Google Scholar
• Steenholdt, C., Andresen, L., Pedersen, G., Hansen, A. & Brynskov, J. Expression and function of toll-like receptor 8 and Tollip in colonic epithelial cells from patients with inflammatory bowel disease. Scand. J. Gastroenterol. 44, 195–204 (2009).
  CAS PubMed Google Scholar
• Kanneganti, T. D., Lamkanfi, M. & Nunez, G. Intracellular NOD-like receptors in host defense and disease. Immunity 27, 549–559 (2007).
  CAS PubMed Google Scholar
• Barnes, P. J. & Karin, M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336, 1066–1071 (1997).
  CAS PubMed Google Scholar
• Salucci, V. et al. Monocyte-derived dendritic cells from Crohn patients show differential NOD2/CARD15-dependent immune responses to bacteria. Inflamm. Bowel Dis. 14, 812–818 (2008).
  PubMed Google Scholar
• Ferwerda, G. et al. Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2. J. Leukoc. Biol. 82, 1011–1018 (2007).
  CAS PubMed Google Scholar
• Brosbol-Ravnborg, A. et al. Toll-like receptor-induced granulocyte–macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways. Clin. Exp. Immunol. 155, 487–495 (2009).
  CAS PubMed PubMed Central Google Scholar
• Hedl, M., Li, J., Cho, J. H. & Abraham, C. Chronic stimulation of Nod2 mediates tolerance to bacterial products. Proc. Natl Acad. Sci. USA 104, 19440–19445 (2007).
  CAS PubMed PubMed Central Google Scholar
• Kramer, M., Netea, M. G., de Jong, D. J., Kullberg, B. J. & Adema, G. J. Impaired dendritic cell function in Crohn's disease patients with NOD2 3020insC mutation. J. Leukoc. Biol. 79, 860–866 (2006).
  CAS PubMed Google Scholar
• Bonen, D. K. et al. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 124, 140–146 (2003).
  CAS PubMed Google Scholar
• Homer, C. R., Richmond, A. L., Rebert, N. A., Achkar, J. P. & McDonald, C. ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis. Gastroenterology 139, 1630–1641 e2 (2010).
  CAS PubMed Google Scholar
• van Beelen, A. J. et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27, 660–669 (2007).
  CAS PubMed Google Scholar
• Perez, L. H. et al. Direct bacterial killing in vitro by recombinant Nod2 is compromised by Crohn's disease-associated mutations. PLoS ONE 5, e10915 (2010).
  PubMed PubMed Central Google Scholar
• Cooney, R. et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat. Med. 16, 90–97 (2010).
  CAS PubMed Google Scholar
• Hisamatsu, T. et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124, 993–1000 (2003).
  CAS PubMed Google Scholar
• Lipinski, S. et al. DUOX2-derived reactive oxygen species are effectors of NOD2-mediated antibacterial responses. J. Cell Sci. 122, 3522–3530 (2009).
  CAS PubMed Google Scholar
• Magalhaes, J. G. et al. Nod2-dependent Th2 polarization of antigen-specific immunity. J. Immunol. 181, 7925–7935 (2008).
  CAS PubMed Google Scholar
• Geddes, K. et al. Nod1 and Nod2 regulation of inflammation in the Salmonella colitis model. Infect. Immun. 78, 5107–5115 (2010).
  CAS PubMed PubMed Central Google Scholar
• Barreau, F. et al. Nod2 regulates the host response towards microflora by modulating T cell function and epithelial permeability in mouse Peyer's patches. Gut 59, 207–217 (2010).
  CAS PubMed Google Scholar
• Girardin, S. E. et al. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300, 1584–1587 (2003).
  CAS PubMed Google Scholar
• McGovern, D. P. et al. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum. Mol. Genet. 14, 1245–1250 (2005).
  CAS PubMed Google Scholar
• Canto, E. et al. Influence of a nucleotide oligomerization domain 1 (NOD1) polymorphism and NOD2 mutant alleles on Crohn's disease phenotype. World J. Gastroenterol. 13, 5446–5453 (2007).
  CAS PubMed PubMed Central Google Scholar
• Tremelling, M. et al. Complex insertion/deletion polymorphism in NOD1 (CARD4) is not associated with inflammatory bowel disease susceptibility in East Anglia panel. Inflamm. Bowel Dis. 12, 967–971 (2006).
  PubMed Google Scholar
• Van Limbergen, J. et al. Contribution of the NOD1/CARD4 insertion/deletion polymorphism +32656 to inflammatory bowel disease in Northern Europe. Inflamm. Bowel Dis. 13, 882–889 (2007).
  CAS PubMed Google Scholar
• Van Limbergen, J. et al. Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy. Hum. Mol. Genet. 16, 2175–2186 (2007).
  CAS PubMed Google Scholar
• Lu, W. G. et al. Association of NOD1 (CARD4) insertion/deletion polymorphism with susceptibility to IBD: a meta-analysis. World J. Gastroenterol. 16, 4348–4356 (2010).
  CAS PubMed PubMed Central Google Scholar
• Hoffman, H. M., Mueller, J. L., Broide, D. H., Wanderer, A. A. & Kolodner, R. D. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat. Genet. 29, 301–305 (2001).
  CAS PubMed PubMed Central Google Scholar
• Villani, A. C. et al. Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat. Genet. 41, 71–76 (2009).
  CAS PubMed Google Scholar
• Lewis, G. J. et al. Genetic association between NLRP3 variants and Crohn's disease does not replicate in a large UK panel. Inflamm Bowel Dis. doi:10.1002/ibd.21499.
  PubMed Google Scholar
• Schoultz, I. et al. Combined polymorphisms in genes encoding the inflammasome components NALP3 and CARD8 confer susceptibility to Crohn's disease in Swedish men. Am. J. Gastroenterol. 104, 1180–1188 (2009).
  CAS PubMed Google Scholar
• Schreiber, S. et al. Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease. Lancet 353, 459–461 (1999).
  CAS PubMed Google Scholar
• Broz, P. et al. Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J. Exp. Med. 207, 1745–1755 (2010).
  CAS PubMed PubMed Central Google Scholar
• Mariathasan, S. et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228–232 (2006).
  CAS PubMed Google Scholar
• Zaki, M. H. et al. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32, 379–391 (2010).
  CAS PubMed PubMed Central Google Scholar
• Mizushima, N., Levine, B., Cuervo, A. M. & Klionsky, D. J. Autophagy fights disease through cellular self-digestion. Nature 451, 1069–1075 (2008).
  CAS PubMed PubMed Central Google Scholar
• Hampe, J. et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39, 207–211 (2007).
  CAS PubMed Google Scholar
• Rioux, J. D. et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 39, 596–604 (2007).
  CAS PubMed PubMed Central Google Scholar
• Weersma, R. K. et al. ATG16L1 and IL23R are associated with inflammatory bowel diseases but not with celiac disease in the Netherlands. Am. J. Gastroenterol. 103, 621–627 (2008).
  CAS PubMed Google Scholar
• Glas, J. et al. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population. Am. J. Gastroenterol. 103, 682–691 (2008).
  CAS PubMed Google Scholar
• Parkes, M. et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat. Genet. 39, 830–832 (2007).
  CAS PubMed PubMed Central Google Scholar
• McCarroll, S. A. et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat. Genet. 40, 1107–1112 (2008).
  CAS PubMed PubMed Central Google Scholar
• Singh, S. B., Davis, A. S., Taylor, G. A. & Deretic, V. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313, 1438–1441 (2006).
  CAS PubMed Google Scholar
• Lapaquette, P., Glasser, A. L., Huett, A., Xavier, R. J. & Darfeuille-Michaud, A. Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell. Microbiol. 12, 99–113 (2010).
  CAS PubMed Google Scholar
• Intemann, C. D. et al. Autophagy gene variant IRGM -261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains. PLoS Pathog. 5, e1000577 (2009).
  PubMed PubMed Central Google Scholar
• Travassos, L. H. et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol. 11, 55–62 (2009).
  PubMed Google Scholar
• Perminow, G. et al. Defective paneth cell-mediated host defense in pediatric ileal Crohn's disease. Am. J. Gastroenterol. 105, 452–459 (2010).
  PubMed Google Scholar
• Wehkamp, J. et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc. Natl Acad. Sci. USA 102, 18129–18134 (2005).
  CAS PubMed PubMed Central Google Scholar
• Wehkamp, J. et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 53, 1658–1664 (2004).
  CAS PubMed PubMed Central Google Scholar
• Cadwell, K. et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456, 259–263 (2008).
  CAS PubMed PubMed Central Google Scholar
• Sim, W. H. et al. Novel Burkholderiales 23S rRNA genes identified in ileal biopsy samples from children: preliminary evidence that a subtype is associated with perianal Crohn's disease. J. Clin. Microbiol. 48, 1939–1942 (2010).
  CAS PubMed PubMed Central Google Scholar
• Van Etterijck, R. et al. Isolation of Campylobacter concisus from feces of children with and without diarrhea. J. Clin. Microbiol. 34, 2304–2306 (1996).
  CAS PubMed PubMed Central Google Scholar
• Kangro, H. O., Chong, S. K., Hardiman, A., Heath, R. B. & Walker-Smith, J. A. A prospective study of viral and Mycoplasma infections in chronic inflammatory bowel disease. Gastroenterology 98, 549–553 (1990).
  CAS PubMed Google Scholar
• Schuller, J. L., Piket-van Ulsen, J., Veeken, I. V., Michel, M. F. & Stolz, E. Antibodies against Chlamydia of lymphogranuloma-venereum type in Crohn's disease. Lancet 1, 19–20 (1979).
  CAS PubMed Google Scholar
• Swidsinski, A., Loening-Baucke, V., Vaneechoutte, M. & Doerffel, Y. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm. Bowel Dis. 14, 147–161 (2008).
  PubMed Google Scholar
• Willing, B. et al. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm. Bowel Dis. 15, 653–660 (2009).
  PubMed Google Scholar
• Sokol, H. et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 15, 1183–1189 (2009).
  CAS PubMed Google Scholar
• Schwiertz, A. et al. Microbiota in pediatric inflammatory bowel disease. J. Pediatr. 157, 240–244 e1 (2010).
  PubMed Google Scholar
• Sokol, H. et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl Acad. Sci. USA 105, 16731–16736 (2008).
  CAS PubMed PubMed Central Google Scholar
• Jia, W. et al. Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease? FEMS Microbiol. Lett. 310, 138–144.
• Luther, J., Dave, M., Higgins, P. D. & Kao, J. Y. Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm. Bowel Dis. 16, 1077–1084 (2010).
  PubMed Google Scholar
• Gutierrez, A. et al. Cytokine association with bacterial DNA in serum of patients with inflammatory bowel disease. Inflamm. Bowel Dis. 15, 508–514 (2009).
  PubMed Google Scholar
• Liu, Y. et al. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology 108, 1396–1404 (1995).
  CAS PubMed Google Scholar
• Chen, W., Li, D., Paulus, B., Wilson, I. & Chadwick, V. S. Detection of Listeria monocytogenes by polymerase chain reaction in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls. J. Gastroenterol. Hepatol. 15, 1145–1150 (2000).
  CAS PubMed Google Scholar
• Chiba, M. et al. Listeria monocytogenes in Crohn's disease. Scand. J. Gastroenterol. 33, 430–434 (1998).
  CAS PubMed Google Scholar
• Qual, D. A., Kaneene, J. B., Varty, T. J., Miller, R. & Thoen, C. O. Lack of association between the occurrence of Crohn's disease and occupational exposure to dairy and beef cattle herds infected with Mycobacterium avium subspecies paratuberculosis. J. Dairy Sci. 93, 2371–2376 (2010).
  CAS PubMed Google Scholar
• Canto, E. et al. TNF alpha production to TLR2 ligands in active IBD patients. Clin. Immunol. 119, 156–165 (2006).
  CAS PubMed Google Scholar
• Ng, M. T. et al. Increase in NF-kappaB binding affinity of the variant C allele of the toll-like receptor 9 -1237T/C polymorphism is associated with _Helicobacter pylori_-induced gastric disease. Infect. Immun. 78, 1345–1352 (2010).
  CAS PubMed Google Scholar
• Molnar, T. et al. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease. Dig. Liver Dis. 39, 1064–1070 (2007).
  CAS PubMed Google Scholar
• Hysi, P. et al. NOD1 variation, immunoglobulin E and asthma. Hum. Mol. Genet. 14, 935–941 (2005).
  CAS PubMed Google Scholar
• Lala, S. et al. Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology 125, 47–57 (2003).
  CAS PubMed Google Scholar
• Seidelin, J. B., Broom, O. J., Olsen, J. & Nielsen, O. H. Evidence for impaired CARD15 signalling in Crohn's disease without disease linked variants. PLoS ONE 4, e7794 (2009).
  PubMed PubMed Central Google Scholar
• Lacher, M. et al. Autophagy 16-like 1 rs2241880 G. allele is associated with Crohn's disease in German children. Acta Paediatr. 98, 1835–1840 (2009).
  CAS PubMed Google Scholar
• von Kampen, O. et al. Caspase recruitment domain-containing protein 8 (CARD8) negatively regulates NOD2-mediated signaling. J. Biol. Chem. 285, 19921–19926 (2010).
  CAS PubMed PubMed Central Google Scholar
• McGovern, D. P. et al. TUCAN (CARD8) genetic variants and inflammatory bowel disease. Gastroenterology 131, 1190–1196 (2006).
  CAS PubMed Google Scholar
• Zhernakova, A. et al. Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. Am. J. Hum. Genet. 82, 1202–1210 (2008).
  CAS PubMed PubMed Central Google Scholar
• Klein, W. et al. A polymorphism in the CD14 gene is associated with Crohn disease. Scand. J. Gastroenterol. 37, 189–191 (2002).
  CAS PubMed Google Scholar
• Yuan, F. F. et al. Clinical relevance of TLR2, TLR4, CD14 and FcgammaRIIA gene polymorphisms in Streptococcus pneumoniae infection. Immunol. Cell Biol. 86, 268–270 (2008).
  CAS PubMed Google Scholar
• Gibot, S., Cariou, A., Drouet, L., Rossignol, M. & Ripoll, L. Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate. Crit. Care Med. 30, 969–973 (2002).
  CAS PubMed Google Scholar
• De Jager, P. L. et al. The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun. 8, 387–397 (2007).
  CAS PubMed Google Scholar